Target intelligence / Profile preview

Glycine-rich peptide motif

Molecular classification
Other
01

Overview

Glycine-rich peptide motifs, most notably the (Gly4Ser)n sequence, are synthetic amino acid chains used as flexible linkers in the design of engineered fusion proteins, such as single-chain variable fragments (scFvs), bispecific antibodies, and chimeric antigen receptors (CARs) (Chen et al., 2013). These motifs are characterized by a high glycine content, which provides the necessary rotational freedom for connected protein domains to fold and function independently. While these motifs are critical components of many modern biotherapeutics, they are not considered therapeutic targets in the traditional sense (e.g., receptors or enzymes). Instead, they are structural elements of the drug molecules themselves. A significant challenge associated with these motifs is their potential immunogenicity; patients may develop anti-drug antibodies (ADAs) specifically targeting the linker sequence, which can reduce the drug's half-life or cause adverse immune reactions (Harding et al., 2010). The phrase "outside peptidoglycan linkers" serves to distinguish these synthetic motifs from the natural glycine-rich cross-bridges (e.g., pentaglycine) found in the cell walls of Gram-positive bacteria like Staphylococcus aureus, which are targets for specialized antimicrobial enzymes like lysostaphin (Bastos et al., 2010). This entry is marked as incorrect because the provided name is a descriptive phrase containing a typo ("peptidoglycann") rather than a canonical biological target.

Other names
Glycine-rich linkerFlexible peptide linker(Gly4Ser)n linkerPolyglycine linkerGS linkerGly-Ser linker
02

Mechanism of action

Provides conformational flexibility and structural spacing between functional domains in engineered fusion proteins to ensure proper folding and binding activity.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

ImmunogenicityProteolytic instabilityAggregationInduction of anti-linker antibodies
06

Biomarkers

Anti-drug antibodies (ADAs)

Beyond the preview

Go deeper on Glycine-rich peptide motif.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycine-rich peptide motif.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call